NATURE Publishes Promising Results on Treatment of First Patient in bluebird bio's Phase 1/2 Beta-Thalassemia Study Read more about NATURE Publishes Promising Results on Treatment of First Patient in bluebird bio's Phase 1/2 Beta-Thalassemia Study
bluebird bio Awarded Two Qualifying Therapeutic Discovery Project Program Grants Read more about bluebird bio Awarded Two Qualifying Therapeutic Discovery Project Program Grants
bluebird bio and Généthon Announce Manufacturing Research Collaboration Centered on Lentiviral Vectors for Gene Therapy Read more about bluebird bio and Généthon Announce Manufacturing Research Collaboration Centered on Lentiviral Vectors for Gene Therapy
Massachusetts Life Sciences Center Announces 2010 Tax Incentives Targeted at Read more about Massachusetts Life Sciences Center Announces 2010 Tax Incentives Targeted at
bluebird bio Awarded up to $4.2 Million from the French Muscular Dystrophy Association for Continued Development of Gene Therapy for Beta-Thalassemia and Sickle Cell Anemia Read more about bluebird bio Awarded up to $4.2 Million from the French Muscular Dystrophy Association for Continued Development of Gene Therapy for Beta-Thalassemia and Sickle Cell Anemia
bluebird bio Appoints World Leading Experts to Inaugural Scientific Advisory Board Read more about bluebird bio Appoints World Leading Experts to Inaugural Scientific Advisory Board
bluebird bio Adds Biotech Industry Veterans to Management Team and Board Read more about bluebird bio Adds Biotech Industry Veterans to Management Team and Board
bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team Read more about bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team
bluebird bio Appoints Two New Members to its Board of Directors Wendy Dixon, Ph.D., and David Schenkein, M.D. Read more about bluebird bio Appoints Two New Members to its Board of Directors Wendy Dixon, Ph.D., and David Schenkein, M.D.
bluebird bio Announces Global Strategic Collaboration with Celgene to Advance Gene Therapy in Oncology Read more about bluebird bio Announces Global Strategic Collaboration with Celgene to Advance Gene Therapy in Oncology